TPD & Induced Proximity Summit Leaderboard
  • Sunday, July 5, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 784

Sinovac Biotech plans to enhance corporate governance

Mar 7, 2018
Sinovac Biotech which is a provider of bio-pharmaceutical products in China has plans to accentuate the corporate governance and management of Sinovac Biotech Co., Ltd, the main…
Read More...

FDA approves IND application for Moleac’s Phase 1 study MLC1501

Mar 6, 2018
Biopharmaceutical company, Moleac that is focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food…
Read More...

Prometic receives Rare Pediatric Disease Designation from FDA

Mar 6, 2018
Prometic Life sciences asserted that the U.S Food and Drug Adminstration has granted a Rare Pediatric Disease Designation to its Inter-Alpha-Inhibitor-Proteins for the treatment of…
Read More...

Vanda Pharmaceutical’s HETLIOZ for symptoms of jet lag disorder

Mar 6, 2018
Vanda Pharmaceuticals asserted that HETLIOZ which is a circadian regulator exhibited significant and clinically meaningful benefits in symptoms of jet lag disorder. Jet lag disorder…
Read More...

MyBiotics signs second option agreement with Ferring Holding for the validation

Mar 6, 2018
MyBiotics Pharma which is a microbiome therapeutics company announced that it has entered into second option agreement with Ferring Holding Ltd. for the validation of MyBiotics'…
Read More...

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Mar 6, 2018
Benitec Biopharma which is a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi…
Read More...

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075

Mar 6, 2018
Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...

Aequus and Ehave venture into collaboration agreement for bioinformatics platform

Mar 6, 2018
In a bid to enhance and streamline data management processes for Aequus- sponsored clinical trials studying specific Cannabinoid-rich formulations for treating a number of neurological…
Read More...

Lyric finishes enrollment in Phase 2 PRROMOTE Study of LP101 in Enteral Feeding Intolerance

Mar 6, 2018
Lyric Pharmaceuticals which is a biopharmaceutical company asserted the completion of enlisting for PROMOTE Study which is an international multi-center, randomized, controlled Phase 2…
Read More...

Glenmark Pharmaceuticals presents New Data on Ryaltris for treating SAR at AAAAI/WAO

Mar 6, 2018
Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...
Previous 1 … 782 783 784 785 786 … 937 Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.